Brief: Hamlet Pharma Enters Into Patent Licensing Agreement

HAMLET Pharma AB

12/05/2020 07:36

May 12 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * HAMLET PHARMA ENTERS INTO PATENT LICENSING AGREEMENT
    * PATENT LICENSING AGREEMENT HAS BEEN SIGNED BETWEEN HAMLET
PHARMA
AB AND LINNANE PHARMA AB
    * AGREEMENT TO SECURE DEVELOPMENT AND COMMERCIALISATION OF
BAMLET
FOR USE OTHER THAN AS A PHARMACEUTICAL.
    * AGREEMENT STIPULATES THAT LINNANE PHARMA AB WILL PAY AN
ANNUAL
ROYALTY OF 10% OF ITS GROSS INCOME TO HAMLET PHARMA AB AS LONG
AS PATENTS PROTECTING USE OF BAMLET ARE VALID

Source text for Eikon:  ID:nWkr2y0qBb 
Further company coverage:  HAMLET.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))